Literature DB >> 16391892

Transverse myelitis, a rare neurological manifestation of mixed connective tissue disease--a case report and a review of literature.

Sumeet Bhinder1, Kevin Harbour, Vikas Majithia.   

Abstract

Although neurological involvement occurs in about 10% of patients with mixed connective tissue disease (MCTD), acute transverse myelitis (TM) has only been described in seven cases of MCTD. We hereby report a case of 70-year-old white female with transverse myelitis complicating her underlying MCTD. Our patient presented with lower extremity weakness, loss of sensation and incontinence one year after her diagnosis of MCTD. Her work-up revealed an abnormal MRI, with findings consistent with TM. She had an excellent response to initial therapy with six cycles of monthly intravenous immunoglobulins and steroids, with subsequent maintenance on azathioprine. She had a good neurological recovery with mild residual sequelae only. On basis of this case report and review of literature, we recommend ongoing surveillance and reporting of this rare neurological presentation in MCTD.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16391892     DOI: 10.1007/s10067-005-0158-1

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  7 in total

1.  Transverse myelopathy, a rare complication of mixed connective tissue disease: comparison with SLE related transverse myelopathy.

Authors:  S J Weatherby; M B Davies; C P Hawkins; N Haq; P Dawes
Journal:  J Neurol Neurosurg Psychiatry       Date:  2000-04       Impact factor: 10.154

2.  Acute transverse myelopathy in systemic lupus erythematosus: clinical presentation, treatment, and outcome.

Authors:  C C Mok; C S Lau; E Y Chan; R W Wong
Journal:  J Rheumatol       Date:  1998-03       Impact factor: 4.666

3.  Transverse myelopathy in systemic lupus erythematosus. Report of three cases and review of the literature.

Authors:  A A Andrianakos; J Duffy; M Suzuki; J T Sharp
Journal:  Ann Intern Med       Date:  1975-11       Impact factor: 25.391

4.  Transverse myelitis in mixed connective tissue disease.

Authors:  C Pedersen; H Bonen; F Boesen
Journal:  Clin Rheumatol       Date:  1987-06       Impact factor: 2.980

5.  Lupus transverse myelopathy: better outcome with early recognition and aggressive high-dose intravenous corticosteroid pulse treatment.

Authors:  V Harisdangkul; D Doorenbos; S H Subramony
Journal:  J Neurol       Date:  1995-05       Impact factor: 4.849

6.  Transverse myelitis in mixed connective tissue disease.

Authors:  T D Weiss; J S Nelson; R M Woolsey; J Zuckner; A R Baldassare
Journal:  Arthritis Rheum       Date:  1978 Nov-Dec

7.  Transverse myelopathy complicating mixed connective tissue disease.

Authors:  C C Mok; C S Lau
Journal:  Clin Neurol Neurosurg       Date:  1995-08       Impact factor: 1.876

  7 in total
  4 in total

Review 1.  Myelopathy associated with mixed connective tissue disease: clinical manifestation, diagnosis, treatment, and prognosis.

Authors:  Yulei Hao; Meiying Xin; Shuang Wang; Di Ma; Jiachun Feng
Journal:  Neurol Sci       Date:  2019-05-21       Impact factor: 3.830

2.  Adhesive arachnoiditis in mixed connective tissue disease: a rare neurological manifestation.

Authors:  Maria Usman Khan; James Anthony Joseph Devlin; Alexander Fraser
Journal:  BMJ Case Rep       Date:  2016-12-16

3.  Etiological profile of noncompressive myelopathies in a tertiary care hospital of Northeast India.

Authors:  Ashok Kumar Kayal; Munindra Goswami; Marami Das; Lakhshya Jyoti Basumatary; Suvorit Subhas Bhowmick; Baiakmenlang Synmon
Journal:  Ann Indian Acad Neurol       Date:  2017 Jan-Mar       Impact factor: 1.383

Review 4.  Transverse myelitis.

Authors:  Shin C Beh; Benjamin M Greenberg; Teresa Frohman; Elliot M Frohman
Journal:  Neurol Clin       Date:  2013-02       Impact factor: 3.806

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.